Ankle arthrosis hits patients victims of a trauma which can generate a fracture (of malleolus or tibia), patients affected by inflammatory systemic diseases (rheumatoid arthritis, lupus, etc.) and storage diseases (haemochromatosis, for instance).
On the other hand, diabetes is a constantly growing pathology, so much that experts talk about “world diabetes epidemic”.

Diabetes numbers in Italy.

In Italy, type 1 diabetes predominance (number of cases) ranges from 0,4% to 1% of population.

Type 2 diabetes predominance can be approximately estimated around 8-11% of population, if examined with focused investigation.

Such significant numbers are, without a doubt, tied to sedentary lifestyles, unbalanced diets, overweight and obesity.

What does it involve in patients?

So, it is clear that even patients affected by ankle arthrosis are not immune to it, either because they already had diabetes before the traumatic event, or because they got the disease afterwars, also due to the sedentary lifestyle which their ankle forces to live.

It is common to think that diabetes is one of the most important failure causes in orthopedic operations.

This often leads us, doctors, to advise diabetic patients against surgical operations, even if they can considerably improve their life quality.

Actually, diabetes mellitus does not represent a priori contraindication to ankle prosthesis operation, as to other orthopedic operations as well.

It is clear that we are talking about compensated diabetes mellitus, with normal values (glycemia, but also glycated hemoglobin).

Therefore, the diabetologist is always fundamental and plays the protagonist!


The latest researches on diabetes and ankle prosthesis.

Undoubtedly, though, this article published on Foot and Ankle International, an influential magazine specialised in ankle and foot surgery, confirms that the diabetic patient may be a candidate for ankle prosthesis without having an intensified risk, compared to the unaffected patients.

We are dealing with data confirmed by our database as well and which Dr. Gross has published while working at “Duke University”, a university I happily remember as part of my training.

Furthermore, Dr. Gross is an American collegue, whom we esteem and work with for different projects.

I am, therefore, glad to publish the results of his research, which gives more serenity to us surgeons and to our diabetic patients.